Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-0428
    Keywords: Potassium ion ; pancreas perfusion ; glucagon, insulin ; experimental diabetes mellitus ; insulin clamp
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary In the arginine-stimulated perfused rat pancreas, elevated concentrations of potassium ion inhibited glucagon secretion while stimulating the secretion of insulin. Decreased potassium ion produced the reverse effect. The observed inverse correlation between changes in insulin and glucagon secretion (r = -0.64; p〈0.001) was suggestive of local interactions between islet hormones, and prompted us to determine whether potassium-induced changes in glucagon secretion were dependent upon concurrent changes in insulin release. We found that when insulin secretion was greatly suppressed, either through acute induction of diabetes with streptozotocin or by utilization of a glucose-free perfusate, no qualitative differences in glucagon responsiveness to altered potassium ion were evident, although the amplitude of these glucagon changes was enhanced. Similarly, when exogenous insulin (20,000 mU/l) was added to the perfusate in order to render potassium-induced changes in endogenous insulin secretion insignificant, glucagon responsiveness to altered potassium ion was maintained. Exogenous insulin alone had no effect on arginine-stimulated glucagon secretion. We conclude that any indirect effects of potassium ion on arginine-stimulated glucagon secretion are not mediated by insulin, but could be related to changes in somatostatin secretion.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-0428
    Keywords: Eviscerated rat ; immunoreactive glucagon (IRG) ; immunoreactive insulin (IRI) ; gel filtration ; submaxillary glands
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Eviscerated rats (animals without gastrointestinal tract or pancreas, but with intact liver and kidneys) are diabetic with blood glucose levels of 287 ± 10 mg% (n = 35) 24 h after surgery. Immunoreactive insulin (IRI) and immunoreactive glucagon (IRG) persisted in these animals at plasma levels of 36 ± 4 μU/ml and 0.29 ± 0.02 ng/ml, respectively. Twenty-four h fasted sham-operated controls, on the other hand, had blood glucose levels of 101 ± 3mg%, plasma IRI levels of 62 ± 8 μU/ml and plasma IRG levels of 0.38 ± 0.05 ng/ml (n = 21). IRG levels were not increased in eviscerated animals by surgical stress, fasting, arginine infusion, or insulin-induced hypoglycaemia, nor did they decrease following somatostatin infusion. IRI levels were similarly unresponsive. An unexplained decrease in IRG followed arginine infusion. Gel filtration studies showed plasma IRI and IRG to consist mainly of the larger molecular weight components with little of the smaller “native hormone” species. The disappearance rates of injected 125I-insulin and 125I-glucagon did not differ from sham-operated controls. Removal of the submaxillary glands from eviscerated animals had no effect on the circulating levels of IRG. Bilateral nephrectomy doubled plasma IRG. It is suggested that persistent IRG and IRI in eviscerated rats represents retained immunoreactive materials with slow rates of degradation, although an unresponsive extravisceral source of IRG can not be ruled out.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-0428
    Keywords: Glucagonoma ; increased plasma “Large glucagon-immunoreactivity”
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Immunoreactive glucagon (IRG) fractions from plasma of 8 normal subjects and 4 patients with glucagon secreting tumors were studied by gel filtration techniques on Bio Gel P-30 and Sephadex G-50 columns. The pancreatic glucagon specific anti serum (30K) of Unger was utilized to measure IRG. Columns were calibrated with labelled albumin, proinsulin, insulin and glucagon. Four peaks were defined in normal and tumor bearing patients: peak I (〉20000 mol. wt.), peak II (primarily 9000 mol. wt.), peak III pancreatic glucagon (3500 mol. wt.) and peak IV small glucagon (〈3500 mol. wt.). Glucagonoma patients differed from our normal and reported normal subjects in that peak II contained most of the circulating IRG. The percent of IRG associated with peak II was 9.5–31.5% in normals and 39.1–61.2% in glucagonomas. Glucagon-like biological activity in an isolated hepatocyte system was demonstrated for all peaks. However, relative to immunoreactivity, peak II showed reduced activity (25–33%). Immunoassay of dilutions of all peaks revealed the probability of immuno determinants identical with porcine pancreatic glucagon. The presence of heterogeneous IRG peaks with biological glucagon-like activity suggest that the larger molecules may be prohormones. Further, it is possible that specific elevation of peak II may be a diagnostic feature of glucagonomas.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 58 (1980), S. 881-887 
    ISSN: 1432-1440
    Keywords: Potassium depletion ; Angiotensin ; Aldosterone ; Norepinephrine ; Vascular sensitivity ; Renal concentrating ability ; Glucose tolerance ; Kaliummangel ; Angiotensin ; Aldosteron ; Noradrenalin ; Gefäßsensitivität ; renales Konzentrationsvermögen ; Glucosetoleranz
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Bei sechs gesunden Versuchspersonen wurde mit Hilfe einer kaliumarmen Diät und dreitägiger Gabe von täglich 40 mg Furosemid eine Kaliumverarmung von 217±16 mÄq mit einem Abfall der Serum Kalium-Konzentration von 4,2±0,1 auf 3,2±0,1 mÄq/l induziert. Körpergewicht, arterieller Blutdruck, Serum Natrium- und Bicarbonat-Konzentrationen, Plasma Cortisol- und Noradrenalin-Konzentrationen, Plasma Renin-Aktivität, Urinvolumen und — Osmolarität, endogene 24 h — Kreatinin-Clearance und die Ausscheidung der 17-Hydroxycorticosteroide im Harn blieben unverändert. Dagegen waren sowohl die Plasma Aldosteron-Konzentration in Ruhe (2,6±0,3 vs. 7,2±2,6 pg/ml;p〈0,01) und nach Orthostase (5,5±1,3 vs. 19,8±8,1 pg/ml;p〈0,01) als auch die Ausscheidung von Aldosteron-18-Glucuronid (1,64±0,14 vs. 3,45±0,61 µg/24 h;p〈0,01) signifikant supprimiert. Während der Blutdruckanstieg unter Infusion von Noradrenalin während Hypokaliämie unverändert blieb, war die Sensitivität gegenüber exogen zugeführtem Angiotensin II signifikant vermindert. Kaliumverarmung hatte keinen Effekt auf die Nüchtern-Glucose-Konzentration, veränderte jedoch die Plasma Glucose-Kinetik nach oraler Gabe von 100 g Glucose, ohne eine pathologische Glucosetoleranz zu bewirken. Die verspätete maximale Plasma Glucose-Konzentration ist dabei mit einer supprimierten Sekretion von Insulin 30 min nach Glucosezufuhr vergesellschaftet (74,0±19,2 vs. 126,0±23,5 µU/ml;p〈0,05). Während der Kaliumverarmung wurden von den Probanden keine subjektiven Beschwerden geäußert. Unsere Untersuchung zeigt, daß eine akute mäßiggradige Kaliumverarmung bei jungen, gesunden Versuchspersonen eine signifikante Suppression der adrenalen Aldosteronsekretion, eine Abnahme der Gefäßsensitivität gegenüber Angiotensin II und eine verzögerte Glucoseutilisation aufgrund einer supprimierten Insulinsekretion bei nicht pathologischer Glucosetoleranz bewirkt.
    Notes: Summary In six healthy volunteers, potassium depletion of 217±16 mEq with a decrease in serum potassium concentration from 4.2±0.1 to 3.2±0.1 mEq/l was induced by a diet low in potassium and furosemide, 40 mg/day over three days. Body weight, arterial blood pressure, serum sodium and bicarbonate concentrations, plasma cortisol and norepinephrine concentrations, plasma renin activity, urine volume and osmolarity, endogenous 24 h creatinine clearance and urinary excretion of 17-hydroxycorticosteroids were unchanged. Potassium depletion significantly decreased supine (2.6±0.3 vs. 7.2±2.6 pg/ml;p〈0.01) and upright plasma aldosterone concentrations (5.5±1.3 vs. 19.8±8.1 pg/ml;p〈0.01) and urinary excretion of aldosterone-18-glucuronide (1.64±0.14 vs. 3.45±0.61 µg/24 h;p〈0.01). The response of arterial blood pressure to exogenous norepinephrine was unchanged by potassium depletion while the vascular sensitivity to exogenous angiotensin II was significantly decreased. Potassium depletion had no effect on fasting plasma glucose or on plasma glucose concentrations following a 100 g oral glucose load but delayed the peak plasma glucose. This was associated with a suppressed early (30 min) insulin response (74.0±19.2 vs. 126.0±23.5 µU/ml;p〈0.05). Potassium depletion was not associated with any subjective complaints on the side of the volunteers. Our studies show that acute moderate potassium depletion in young healthy volunteers significantly suppresses adrenal aldosterone secretion and decreases the vascular sensitivity to exogenous angiotensin II. Furthermore, it is associated with a delayed glucose utilization due to decreased insulin secretion but does not impair overall glucose tolerance.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...